Table 4. ReDO drugs included in late-phase clinical trials.
| Item | |
|---|---|
| Number of relevant late-stage trials | 190 |
| Number of unique drugs | 72 |
| Number of drugs with 5 or more trials | 11 |
| Number of drugs with 10 or more trials | 6 |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.